Concepedia

Gilles Rademaker

GR

Statistics

Publications

13

Citations

670

H-Index

12

Active since

2018

Affiliations

University of Liège(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, San Francisco

University of California, Berkeley

Maastricht University

Gilles Rademaker is an author at University of Liège specializing in molecular oncology, oncology, and life sciences.

ORCID

Publications per year

2018–2025

13

Publications

13

Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells

Gilles Rademaker, Yasmine Boumahd, Raphaël Peiffer et al. · Redox Biology · 2022 · 133 citations · Full text

, , +12

Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration

Brunella Costanza, Gilles Rademaker, Assia Tiamiou et al. · International Journal of Cancer · 2019 · 119 citations · Full text

, , +17

Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer

Marie‐Julie Nokin, Justine Bellier, Florence Durieux et al. · Breast Cancer Research · 2019 · 103 citations · Full text

, , +17

Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth

Suprit Gupta, Julian Yano, Vincent Mercier et al. · Nature Cell Biology · 2021 · 73 citations · Full text

, , +15

Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Gilles Rademaker, Vincent Hennequière, Laura Brohée et al. · Oncogene · 2018 · 61 citations · Full text

, , +17

1–5 of 13